Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKinsey
Baxter
Medtronic
Boehringer Ingelheim

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: IVERMECTIN


Email this page to a colleague

« Back to Dashboard

ABAMECTIN

CASRN: 71751-41-2

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Colorcon
AstraZeneca
Medtronic
Moodys